<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genmab A/S

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline and three proprietary next generation antibody technologies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $1,100,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan G. J. van de Winkel, Ph.D.
    • FOUNDED
      1999
    • EMPLOYEES
      251-500
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Community Ventures

    Community Ventures is a non-profit organization that fosters local community econo...

    Community Ventures is a non-profit organization...

    Amount Raised:    $730,000
    Fundraising Status:    VT
    Filing Type:    CF
    Atrion Corporation

    Atrion Corporation

    As a leading manufacturer of medical devices and components, Atrion makes a wide r...

    As a leading manufacturer of medical devices an...

    Filing Type:    PU
    Cytokinetics, Incorporated

    Cytokinetics, Incorporated

    Cytokinetics is a late-stage biopharmaceutical company focused on discovering, dev...

    Cytokinetics is a late-stage biopharmaceutical ...

    Filing Type:    PU
    Neopenda, PBC

    Neopenda, PBC

    Neopenda is a medical device startup creating solutions that give patients in low-...

    Neopenda is a medical device startup creating s...

    Amount Raised:    $288,184.00
    Fundraising Status:    EC
    Filing Type:    CF
    Quotient Limited

    Quotient Limited

    We are an established, commercial-stage diagnostics company committed to reducing ...

    We are an established, commercial-stage diagnos...

    Filing Type:    PU
    Interpace Diagnostics Group, Inc.

    Interpace Diagnostics Group, Inc.

    Interpace Diagnostics is focused on developing and commercializing molecular diagn...

    Interpace Diagnostics is focused on developing ...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Molecular Templates, Inc.

    Molecular Templates, Inc.

    Molecular Templates is focused on the discovery, development, and commercializatio...

    Molecular Templates is focused on the discovery...

    Filing Type:    PU
    Inovio Pharmaceuticals, Inc.

    Inovio Pharmaceuticals, Inc.

    Inovio is bringing IMMUNO-INGENUITY™ to life and is reshaping the future of trea...

    Inovio is bringing IMMUNO-INGENUITY™ to life ...

    Filing Type:    PU
    Check-Cap Ltd.

    Check-Cap Ltd.

    Check-Cap is a clinical-stage medical diagnostics company developing C-ScanÂŽ, the...

    Check-Cap is a clinical-stage medical diagnosti...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.